Chrysalis Pharma AG
Records under this name other than patents Chrysalis Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Chrysalis Pharma AG
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,383,678 | Type a gelatin capsule containing PUFA in free acid form Formerly held Lapsed on the fee record Ended Feb 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2025 | From the USPTO record |
| US 9,132,112 | Type A gelatin capsule containing PUFA in free acid form Lapsed on the fee record Ended Sep 15, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2023 | From the USPTO record |
| US 7,960,370 | Type A gelatin capsule containing PUFA in free acid form Formerly held Lapsed on the fee record Ended Jun 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2023 | From the USPTO record |
| US 10,314,789 | Soft gelatin encapsulated pharmaceutical composition of cis-5,8,11,14,17-eicosapentaenoic acid in free acid form and cis-7,10,13,16,19-docosapentaenoic acid in free acid form Lapsed on the fee record Ended Jun 11, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2023 | From the USPTO record |
| US 9,050,308 | DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form Formerly held Lapsed on the fee record Ended Jun 9, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2023 | From the USPTO record |
| US 9,050,309 | DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form Lapsed on the fee record Ended Jun 9, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2023 | From the USPTO record |
| US 9,012,501 | Type A gelatin capsule containing PUFA in free acid form Lapsed on the fee record Ended Apr 21, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 21, 2023 | From the USPTO record |
| US 10,117,844 | DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form Lapsed on the fee record Ended Nov 6, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2022 | From the USPTO record |
| US 5,792,795 | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids Term ended Term ended no later than Aug 11, 2018 · Low confidence | Term ended | Term ended no later than Aug 11, 2018 | Low confidence |
| US 5,948,818 | Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids Formerly held Term ended Term ended no later than Sep 7, 2019 · Low confidence | Term ended | Term ended no later than Sep 7, 2019 | Low confidence |